Skip to main content

ID Faculty Members, Fellows Present Studies During ID Week

October 10, 2024
ID Week took place October 16-19 in Los Angeles, CA, the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists. UNC’s Division of Infectious Diseases was...

Q&A: Investigators Discuss AMR Research at UNC’s Institute for Global Health and Infectious Diseases

May 16, 2024
Antimicrobial Resistant (AMR) research at the UNC Institute for Global Health and Infectious Diseases brings together collaborators from schools and departments across UNC. Following is an interview with David van Duin, MD, PhD, Brian Conlon, PhD, Luther Bartelt, MD, Tessa Andermann, MD, MPH, and Jonathan Juliano, MD, MSPH, DTM&H. Why is...

Study Finds Increased Risk for Hospital-Acquired Bloodstream Infections Among Racial and Ethnic Minorities

May 16, 2024
A nationwide analysis of a large, geographically diverse cohort of adults in the U.S. suggests there is an increased risk for hospital-acquired carbapenem-resistant enterobacterales (CRE) bloodstream infections among racial and ethnic minorities. Felicia Ruffin, PhD, is a researcher at Duke University School of Medicine in the research group of Vance...

An Opportunist Infection Following a Lung Transplant: Research Participant Shares His Story

May 14, 2024
Matthew Burns, age 33, was diagnosed with cystic fibrosis as a child, and for years experienced repeated lung infections. When the need for intravenous therapy and oxygen became more frequent, he received a lung transplant, a lifesaving opportunity for hope and healing. But a transplant surgery that might typically require...

‘Climate Change and Global Health’ During University Research Week

October 11, 2023
Climate change has been described as the single biggest health threat facing humanity. Physician-researchers through the Institute for Global Health and Infectious Diseases (IGHID), UNC’s engine for global health research, are actively engaged in a variety of efforts to prepare and protect the health of the most vulnerable populations. Some...

Treatment-resistant infections, a “slow-moving catastrophe”

October 11, 2023
From discovery to prevention to treatment, researchers at UNC-Chapel Hill are working to understand and mitigate the global rise of untreatable infections. Nearly every one of us has had an ailment that was treated with an antibiotic. Think about what would happen if that treatment didn’t work. More than 2.8...

IAMIGHID: Spotlighting the AMR Collaborators

April 29, 2023
IGHID has a new hub of collaborative work focused on combating antimicrobial resistance (AMR).  Leveraging the Institute’s pan-university framework, the program brings together expertise in basic science, pharmacology, epidemiology, clinical research and environmental studies from schools and departments all across UNC. Led by David van Duin, MD, PhD, Gauri Rao,...

Institute research sampling, 2018-2020

July 7, 2020
By the spring of 2020, the urgency of the COVID-19 pandemic caused many researchers affiliated with UNC’s Institute for Global Health and Infectious Diseases to pivot their studies to focus on testing, treatment and prevention of the SARS-CoV-2 virus. Here, a look at some of the projects underway in the...

Study finds three strains of resistant bacteria, identifying greater diversity

May 14, 2020
    A new study by the Multi-Drug-Resistant Organism Network of the Antibacterial Resistance Leadership Group (ARLG) has found that strains of carbapenem-resistant enterobacterales (CRE), a major threat to vulnerable patient populations, are more diverse than previously thought. The MDRO Network is led by UNC Infectious Diseases investigator David van...